Cover Image
市場調查報告書

MediPoint:運動醫學 - 南美市場分析與預測

MediPoint: Sports Medicine - South America Analysis and Market Forecasts

出版商 GlobalData 商品編碼 299752
出版日期 內容資訊 英文 174 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:運動醫學 - 南美市場分析與預測 MediPoint: Sports Medicine - South America Analysis and Market Forecasts
出版日期: 2014年03月31日 內容資訊: 英文 174 Pages
簡介

巴西政府營運的醫療保險佔80%佔有率,但醫療費給付額低,包含運動醫學的醫療市場成本障礙變得非常高。(與美國比較)市場不穩定,醫療費給付標準頻繁變更為其原因。儘管如此,包含軍事取向高品質產品的巨大市場,公共領域的市場規模非常大,對外資型企業來說是良好目標。

本報告提供南美各國(巴西等)的運動醫學市場(移植、內視鏡檢驗用設備)相關分析,疾病概要和市場結構,目前未滿足需求,主要的推動及阻礙市場要素,今後的市場機會,現在臨床實驗中的主要產品,南美市場趨勢(過去3年的實際成果值和今後7年的預測值),各類型產品的詳細趨勢,再加上主要企業簡介等調查,並將結果概述為以下內容。

第1章 目錄

第2章 簡介

第3章 臨床結果

  • 保存療法
    • 患部固定和矯正器具
    • 理療
    • 肌肉刺激
  • 藥物療法
    • 營養補充劑
    • 止痛藥和NSAID(非類固醇消炎劑)
    • 皮質類固醇(皮質類固醇)
    • 關節內粘稠補充療法
  • 軟組織的修復
  • 關節鏡檢查
  • 板和螺釘
  • 關節重建

第4章 產業概要

  • 概要
  • 是治療的趨勢:南美的情況
  • 是市場進入:南美的情況
  • 糾紛與解決(共4件)
  • 企業合併、收購(M&A)、夥伴關係、其他資本交易(共9件)
  • 經濟上的影響
    • 先進國家市場的情況
    • 新興國家市場的情況

第5章 未滿足需求

  • 長期性的臨床資料
    • 股關節移植的內視鏡手術的情況
    • 肩迴旋肌損傷的情況
  • 軟骨、半月軟骨修複用產品的開發
    • 半月軟骨的治療
    • 髖關節用的軟骨產品的開發
  • 早期治癒的生技藥品
  • 設備的標準化與改善
    • 髖關節、肩關節用的器具類
    • 螺絲起子的標準化
  • 專門實習醫生的訓練計劃
  • 高級材料的研究
  • 生物吸收性技術的開發
  • 集中化
  • 成本控制的必要性
  • 縫合錨釘產品的開發

第6章 市場機會分析

  • 訓練計劃的追加
  • 產品線的擴張
  • 在運動醫學領域缺乏價格壓力
  • 企業合併、收購(M&A)
  • 運動醫學的季節性
  • 新興國家市場
  • 微創手術的偏好

第7章 市場促進、阻礙因素與替代要素

  • 推動市場要素:相關疾病的得病率的上升
    • 運動相關的損傷
    • 老化
    • 外傷
  • 推動市場要素:髖關節的內視鏡檢驗
    • 大腿髖骨臼撞擊的成長
    • 髖關節內視鏡檢驗的專門醫生訓練計劃
  • 推動市場要素:膝關節、肩關節的內視鏡檢驗
  • 推動市場要素:重新置換手術
  • 推動市場要素:患者的要求和認知度
  • 推動市場要素:生物性骨材的發展
    • 骨移植片
    • 多血小板血漿
  • 推動市場要素:小企業的競爭激烈與創新
  • 推動市場要素:材料的開發
    • 複合材料和生物聚合物
    • 生物吸收性材料
    • 整形外科用的金屬合金
  • 市場阻礙因素:對內視鏡檢驗成果的疑問
    • 髖關節的情況
    • 膝關節的情況
  • 市場阻礙因素:陡峭的學習曲線
  • 市場阻礙因素:醫療費給付
  • 市場阻礙因素:強化法規的負擔
  • 市場阻礙因素:功效的改善
  • 市場阻礙因素:醫療設備的物品稅
  • 替代的因素:傳統開刀手術 vs. 微創內視鏡手術
  • 替代的因素:保存療法的選擇

第8章 競爭企業的評估

  • 概要
  • 已上市產品(共8家份)

第9章 開發平台評估

  • 概要
  • 產品簡介(共8個產品)

第10章 值得注意的臨床實驗(共13件)

第11章 現在、未來市場參與企業

  • 企業策略的趨勢
  • 企業簡介(共9家份)
    • Arthrex
    • ArthroCare Corporation
    • Biomet
    • ConMed Corporation
    • DePuy Companies
    • Smith & Nephew
    • Stryker
    • Tornier
    • Wright Medical Group
    • 其他的企業

第12章 市場未來展望

  • 各企業的市場佔有率
    • 全球
    • 南美
  • 各地區的市場預測:南美的情況

第13章 附錄

圖表一覽

目錄
Product Code: GDME1094CFR

This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports medicine market has been estimated in this report and covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compound annual growth rates (CAGR). GlobalData's analysis shows that while the orthopedics implant market is mature, sports medicine is an area with the potential for significant international growth. With the market, the US remains to be the largest market with the EU to follow and growing. The APAC region while markedly smaller has a large potential patient population.The top six to seven market leaders continue to dominate the market through technological innovation and investment in establishing strong distribution networks. The major opportunity lies within technological advancement and the clinical trials to prove effectiveness of new techniques.

The health insurance system in Brazil is largely government-run, with around 80% of the population covered by the public system. Under this mechanism, we can expect cost barriers with poor reimbursement rates. The key factor in the Brazilian healthcare market is its relative instability compared with a country like the US, and the fact that reimbursement is highly subject to change. The public sector though remains the big market due to military purchasing for high quality use which would be the major target for multinational firms.

Scope

  • An overview of sports medicine, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized SA sports medicine market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
  • Investigation of current and future market competition for sports medicine.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the sports medicine sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

  • Understand the trends shaping and driving SA sports medicine market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in SA sports medicine market through 2018.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in SA sports medicine market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Clinical Outcomes

  • 3.1. Conservative Treatments
    • 3.1.1. Immobilization and Bracing
    • 3.1.2. Physical Therapy
    • 3.1.3. Muscle Stimulation
  • 3.2. Drug Therapy
    • 3.2.1. Nutritional Supplements
    • 3.2.2. Analgesics and NSAIDs
    • 3.2.3. Corticosteroids
    • 3.2.4. Viscosupplementation
  • 3.3. Soft Tissue Repair
  • 3.4. Arthroscopy
  • 3.5. Plates and Screws
  • 3.6. Joint Replacement

4. Industry Overview

  • 4.1. Overview
  • 4.2. Procedure Trends
    • 4.2.1. South America
  • 4.3. Market Access
    • 4.3.1. South America
  • 4.4. Disputes and Settlements
    • 4.4.1. Smith & Nephew Granted an Injunction Against Arthrex
    • 4.4.2. KFx Medical and Smith & Nephew Enter Into Licensing Agreement
    • 4.4.3. KFx Medical Wins Patent Infringement Lawsuit Against Arthrex
    • 4.4.4. ArthroCare and Smith & Nephew Settle Legal Disputes
  • 4.5. Mergers, Acquisitions, Partnerships, and Other Deals
    • 4.5.1. Stryker Acquires Pivot Medical
    • 4.5.2. Smith & Nephew Announces Acquisition of ArthroCare
    • 4.5.3. Smith & Nephew Acquires Plato Grup Assets
    • 4.5.4. Smith & Nephew Announces Acquisition of Its Brazil Distribution Business
    • 4.5.5. Kensey Nash Acquires Minority Stake in Orteq Sports Medicine
    • 4.5.6. Tornier Acquires C2M Medical
    • 4.5.7. Tornier Signs Licensing Agreement with T.A.G. Medical Products Corporation
    • 4.5.8. Biomet Acquires Cartilix
    • 4.5.9. Biomet Sports Medicine Enters Into Deal With Marc Tec
  • 4.6. Economic Impact
    • 4.6.1. Developed Countries
    • 4.6.2. Emerging Markets

5. Unmet Needs

  • 5.1. Long-Term Clinical Data
    • 5.1.1. Hip Arthroscopic Implants Clinical Data
    • 5.1.2. Rotator Cuff Injury Clinical Data
  • 5.2. Cartilage and Meniscal Repair Product Development
    • 5.2.1. Knee Meniscus Treatment
    • 5.2.2. Hip Cartilage Product Development
  • 5.3. Biologics for Faster Healing
  • 5.4. Standardization and Improvement of Instruments
    • 5.4.1. Hip and Shoulder Instrumentation
    • 5.4.2. Screwdriver Standardization
  • 5.5. Fellowship Training Programs
  • 5.6. Advanced Materials Research
  • 5.7. Bioabsorbable Technology Development
  • 5.8. Centralization
  • 5.9. Need for Cost-Containment
  • 5.10. Suture Anchor Product Development

6. Market Opportunity Analysis

  • 6.1. Adding More Training Programs
  • 6.2. Product Line Extensions
  • 6.3. Lack of Pricing Pressure in Sports Medicine
  • 6.4. Mergers and Acquisitions
  • 6.5. Seasonality of Sports Medicine
  • 6.6. Emerging Markets
  • 6.7. Minimally-Invasive Surgical Preference

7. Market Drivers, Barriers and Substitutes

  • 7.1. Driver: Rising Prevalence
    • 7.1.1. Sports-Related Injuries
    • 7.1.2. Aging
    • 7.1.3. Trauma
  • 7.2. Driver: Hip Arthroscopy
    • 7.2.1. Femoroacetabular Impingement Growth
    • 7.2.2. Hip Arthroscopy Fellowship Training Programs
  • 7.3. Driver: Knee and Shoulder Arthroscopy
  • 7.4. Driver: Revision Surgery
  • 7.5. Driver: Patient Demand and Awareness
  • 7.6. Driver: Orthobiologics Development
    • 7.6.1. Bone Grafts
    • 7.6.2. Platelet-Rich Plasma
  • 7.7. Driver: Rising Competition and Innovation Through Small Players
  • 7.8. Driver: Materials Development
    • 7.8.1. Composite Materials and Biopolymers
    • 7.8.2. Bioabsorbables
    • 7.8.3. Metallic Alloys in Orthopedics
  • 7.9. Barrier: Arthroscopy's Questionable Outcomes
    • 7.9.1. Hip Arthroscopy
    • 7.9.2. Knee Arthroscopy
  • 7.10. Barrier: Steep Learning Curve
  • 7.11. Barrier: Reimbursement
  • 7.12. Barrier: Burden of Rising Regulation
  • 7.13. Barrier: Proving Efficacy
  • 7.14. Barrier: Medical Device Excise Tax
  • 7.15. Substitute: Open Surgery Versus Minimally-Invasive Arthroscopy
  • 7.16. Substitute: Conservative Treatment Options

8. Competitive Assessment

  • 8.1. Overview
  • 8.2. Marketed Products in Sports Medicine
    • 8.2.1. Arthrex
    • 8.2.2. ArthroCare Corporation
    • 8.2.3. Biomet
    • 8.2.4. ConMed Corporation
    • 8.2.5. DePuy Mitek
    • 8.2.6. Smith & Nephew
    • 8.2.7. Stryker
    • 8.2.8. Tornier

9. Pipeline Assessment

  • 9.1. Overview
  • 9.2. Product Profiles
    • 9.2.1. Bioretec Drug-Releasing Screws
    • 9.2.2. Nanova Bioabsorbable Bone Screws
    • 9.2.3. MinInvasive Arthroscopic Suture Passer
    • 9.2.4. SpineSmith Pipeline
    • 9.2.5. DePuy Mitek FMS VUE
    • 9.2.6. Pivot Medical Hip Arthroscopy System
    • 9.2.7. University of Florida Shoulder Labral Anchor Delivery System
    • 9.2.8. University of California at San Diego Cartilage Regeneration Device

10. Clinical Trials to Watch

  • 10.1. Overview
  • 10.2. Can Shoulder Arthroscopy Work (CSAW) Study
  • 10.3. Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear
  • 10.4. Knee Arthroscopy Cohort Southern Denmark
  • 10.5. Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement
  • 10.6. Femoroacetabular Impingement Randomized Controlled Trial
  • 10.7. Multicenter ACL Revision Study (MARS)
  • 10.8. Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability
  • 10.9. Microfracture in the Knee Study
  • 10.10. Single- Versus Double-Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears
  • 10.11. Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE)
  • 10.12. Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty
  • 10.13. Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma
  • 10.14. Tibial Tunnel Widening in ACL Reconstruction-Comparing Two Bioscrews

11. Current and Future Players

  • 11.1. Trends in Corporate Strategy
  • 11.2. Company Profiles
    • 11.2.1. Arthrex
    • 11.2.2. ArthroCare Corporation
    • 11.2.3. Biomet
    • 11.2.4. ConMed Corporation
    • 11.2.5. DePuy Companies
    • 11.2.6. Smith & Nephew
    • 11.2.7. Stryker
    • 11.2.8. Tornier
    • 11.2.9. Wright Medical Group
    • 11.2.10. Other Key Players in Sports Medicine

12. Market Outlook

  • 12.1. Company Market Share
    • 12.1.1. Overview
    • 12.1.2. South America Market Share
  • 12.2. By Geography
    • 12.2.1. South America

13. Appendix

  • 13.1. Bibliography
  • 13.2. Abbreviations
  • 13.3. Research Methodology
    • 13.3.1. Overview
    • 13.3.2. Coverage
    • 13.3.3. Secondary Research
  • 13.4. Physicians and Specialists Included in this Study
    • 13.4.1. Dr. Henry D.E. Atkinson
    • 13.4.2. Dr. Joshua Alpert
    • 13.4.3. Dr. Andrea Ferretti
    • 13.4.4. Dr. Alejandro Gonzalez Della Valle
    • 13.4.5. Dr. Andreas Imhoff
    • 13.4.6. Dr. Marcello Zaia Oliveira
    • 13.4.7. Dr. Vidhya Ravi
    • 13.4.8. Dr. Elvire Servien
    • 13.4.9. Dr. Yotaro Yamakado
  • 13.5. Primary Research
    • 13.5.1. Primary Research - Key Opinion Leader Interviews
    • 13.5.2. Primary Research - Physician and Industry Interviews
    • 13.5.3. Expert Panel Validation
  • 13.6. Forecasting Methodology
  • 13.7. About the Authors
    • 13.7.1. Analysts
    • 13.7.2. Global Head of Healthcare
  • 13.8. About MediPoint
  • 13.9. About GlobalData
  • 13.10. Disclaimer

List of Tables

  • Table 1: Most Common Soft Tissue Injuries to the Extremities in Sports Medicine
  • Table 2: Brazil Growth Rate for Arthroscopy by Joint, 2013-2020
  • Table 3: Direct, Indirect, and Intangible Costs of Orthopedics
  • Table 4: Potential Market for Meniscus Treatment Types
  • Table 5: Metal Implant CharacteristicsThat Can Be Improved
  • Table 6: Arthrex Shoulder Implants
  • Table 7: Arthrex, Shoulder Instrumentation
  • Table 8: Arthrex, Knee Sutures and Suture Anchors
  • Table 9: Arthrex, Knee Graft Fixation Devices and Meniscal Products
  • Table 10: Arthrex, Hip Implants and Instruments
  • Table 11: Arthrex, Arthroscopy Procedure Capital Equipment
  • Table 12: Arthrex, Implants SWOT Analysis
  • Table 13: Arthrex, Instrumentation SWOT Analysis
  • Table 14: Arthrocare, Suture Implants
  • Table 15: ArthroCare, Suture Management Products
  • Table 16: ArthroCare, Cruciate Ligament Graft Fixation Products
  • Table 17: ArthroCare, Capital Equipment and Instruments
  • Table 18: ArthroCare, Implants SWOT Analysis
  • Table 19: Arthrocare, Instruments and Capital Equipment SWOT Analysis
  • Table 20: Biomet, Shoulder Arthroscopy Products
  • Table 21: Biomet, Knee Arthroscopy Products
  • Table 22: Biomet's Other Joints Arthroscopy Products
  • Table 23: Biomet, Capital Equipment Sports Medicine Products
  • Table 24: Biomet Implants SWOT Analysis
  • Table 25: Biomet, Capital Equipment SWOT Analysis
  • Table 26: ConMed, Shoulder Arthroscopy Products
  • Table 27: ConMed, Knee Arthroscopy Products
  • Table 28: ConMed, Small Joint and Hip Arthroscopy Products
  • Table 29: ConMed, Instruments and Capital Equipment
  • Table 30: ConMed, Implants SWOT Analysis
  • Table 31: ConMed, Capital Equipment SWOT Analysis
  • Table 32: DePuy Mitek, Fixation Devices
  • Table 33: DePuy, Mitek Instruments
  • Table 34: DePuy Mitek, Capital Equipment
  • Table 35: DePuy Mitek Implants, SWOT Analysis
  • Table 36: DePuy Mitek, Capital Equipment SWOT Analysis
  • Table 37: Smith & Nephew, Fixation Devices
  • Table 38: Smith & Nephew, Instruments and Capital Equipment
  • Table 39: Smith & Nephew Implants, SWOT Analysis
  • Table 40: Smith & Nephew, Capital Equipment SWOT Analysis
  • Table 41: Stryker, Fixation Devices
  • Table 42: Stryker, Instrumentation
  • Table 43: Stryker, Capital Equipment
  • Table 44: Stryker, Fixation Devices SWOT Analysis
  • Table 45: Stryker, Instrumentation and Capital Equipment SWOT Analysis
  • Table 46: Tornier Sports Medicine Products
  • Table 47: Tornier, Product Family SWOT Analysis
  • Table 48: Can Shoulder Arthroscopy Work (CSAW)
  • Table 49: Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear
  • Table 50: Knee Arthroscopy Cohort Southern Denmark
  • Table 51: Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement
  • Table 52: Femoroacetabular Impingement Randomized Controlled Trial
  • Table 53: Multicenter ACL Revision Study (MARS)
  • Table 54: Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability
  • Table 55: Results at 10 to 14 Years After Microfracture in the Knee
  • Table 56: Single Versus Double Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears
  • Table 57: Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE)
  • Table 58: Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty
  • Table 59: Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma in Large to Massive Tears
  • Table 60: Tibial Tunnel Widening in Anterior Cruciate Ligament Reconstruction Comparing Two Bioscrews
  • Table 61: Company Profile - Arthrex
  • Table 62: SWOT Analysis - Arthrex
  • Table 63: Company Profile - ArthroCare Corporation
  • Table 64: SWOT Analysis - ArthroCare Corporation
  • Table 65: Company Profile - Biomet
  • Table 66: SWOT Analysis - Biomet
  • Table 67: Company Profile - ConMed Corporation
  • Table 68: SWOT Analysis - ConMed Corporation
  • Table 69: Company Profile - DePuy Companies
  • Table 70: SWOT Analysis - DePuy Companies
  • Table 71: Company Profile - Smith & Nephew
  • Table 72: SWOT Analysis - Smith & Nephew
  • Table 73: Company Profile - Stryker
  • Table 74: SWOT Analysis - Stryker
  • Table 75: Company Profile - Tornier
  • Table 76: SWOT Analysis - Tornier
  • Table 77: Company Profile - Wright Medical Group
  • Table 78: SWOT Analysis - Wright Medical Group
  • Table 79: Other Sports Medicine Companies in the US Market
  • Table 80: Other Sports Medicine Companies in the EU Market
  • Table 81: Other Sports Medicine Companies in the APAC Market
  • Table 82: Brazil Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 83: Primary Research Interviews Completed in Sports Medicine

List of Figures

  • Figure 1: Brazil Arthroscopic Procedure Volumes, 2011-2020
  • Figure 2: Brazil Arthroscopic Procedure Volumes by Joint, 2011-2020
  • Figure 3: Sources of Orthopedic Trauma (%) (n=103)
  • Figure 4: Brazil Market Share for Arthroscopy, 2012
  • Figure 5: Brazil Sports Medicine Sales Forecast ($m), 2011-2020
Back to Top